本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Belite Bio, Inc.

175.79
+2.001.15%
成交量:3.90萬
成交額:683.87萬
市值:70.79億
市盈率:-64.20
高:178.05
開:172.98
低:172.98
收:173.79
52周最高:200.00
52周最低:64.80
股本:4,027.21萬
流通股本:1,938.28萬
量比:0.25
換手率:0.20%
股息:- -
股息率:- -
每股收益(TTM):-2.7382
每股收益(LYR):-2.3141
淨資產收益率:-22.10%
總資產收益率:-15.65%
市淨率:9.12
市盈率(LYR):-75.96

資料載入中...

2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/25

SEC問詢函

Form CORRESP - Correspondence
2023/05/05

SEC問詢函

Form CORRESP - Correspondence
2023/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/07/08

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/27

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/04/25

SEC問詢函

CORRESP [Cover] - Correspondence